Compare iShares JPMorgan USD Emerging Markets Bond ETF (EMB) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares JPMorgan USD Emerging Markets Bond ETF vs UnitedHealth Group Inc — how do they compare? iShares JPMorgan USD Emerging Markets Bond ETF trades at $95.06, while UnitedHealth Group Inc trades at $404.42 (market cap $361.00B). The key difference: UnitedHealth Group Inc pays a 2.31% dividend while iShares JPMorgan USD Emerging Markets Bond ETF pays none, and UnitedHealth Group Inc is trading nearer its 52-week high, iShares JPMorgan USD Emerging Markets Bond ETF nearer its low. Which is the better fit depends on your goals.
| EMB | UNH | |
|---|---|---|
Sector | Fixed Income | Health |
52-Week High | $97.74 | $436.35 |
52-Week Low | $92.95 | $259.02 |
Market Cap | — | $361.00B |
Enterprise Value | — | $402.86B |
Dividend Yield | — | 2.31% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EMB trades at $94.99 with minimal daily movement (+0.16%), showing technical bearish signals from moving averages while oscillators remain neutral. The stock faces significant selling pressure with support and resistance clustered around $95. Recent corporate actions include scheduled dividend payments through mid-2026, though key financial ratios remain undisclosed in current filings.
The outlook remains cautious with technical indicators favoring sellers and limited fundamental data available. Investment opportunity centers on dividend income stream, while risks include emerging market sovereign default exposure and Federal Reserve policy sensitivity. Analyst sentiment suggests limited upside potential beyond current yield returns.
UnitedHealth Group (UNH) trades at $408.74, showing modest daily gains of 0.41% amid a bearish technical signal. The company demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust analyst support (82.7% buy ratings). Recent developments include dividend payments and strategic initiatives to streamline pediatric care authorizations, positioning UNH well in the healthcare sector.
UNH presents a compelling investment case with strong cash flow generation and market leadership, though investors face risks from regulatory scrutiny and margin compression. The stock trades at a discount to analyst consensus target of $476.50, offering potential upside if operational improvements and growth initiatives materialize as projected.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares JPMorgan USD Emerging Markets Bond ETF
EMB invests in U.S. dollar-denominated sovereign debt from emerging market countries. It provides exposure to government bonds from dozens of nations like Turkey, Mexico, and Brazil, offering a way to seek higher yields and geographic diversification.
Read more on EMB →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
